MedForce

MedForce is a specialized provider of medical communication services, enhancing interactions between life science companies and healthcare professionals through strategic and compliant solutions. Founded in 2001 and headquartered in Shrewsbury, US, MedForce specializes in medical communication services. It was acquired by Eureka Growth Capital in June 2016, with financial terms undisclosed. The CEO is Scott Navitsky.

MedForce, an IQVIA business, specializes in delivering comprehensive medical communication services designed to enhance the connection between life science companies and healthcare professionals (HCPs). Their core offerings encompass a range of solutions focused on medical writing, strategic communication planning, and event logistics, all aimed at simplifying complex scientific information for diverse audiences. The company serves a varied client base, including biopharmaceutical firms and healthcare entities, focusing on the delivery of clear, impactful narratives that resonate with targeted stakeholders. Geographically, MedForce operates in various markets, including North America and Europe, ensuring that their services meet the compliance and engagement needs of clients across these regions.

The firm emphasizes a strong commitment to compliance and client collaboration, which are integral to their service delivery. The revenue model of MedForce is primarily structured around business-to-business transactions, wherein the company engages directly with clients in the life sciences sector for comprehensive communication solutions. Revenue is generated through customized service agreements, which often include a combination of project-based fees and ongoing partnerships. These engagements may involve multi-faceted contracts covering medical writing, event management, and compliance consulting, all tailored to specific client needs.

While the pricing structure for services may vary based on project scope and complexity, MedForce maintains a focus on delivering high-quality, value-driven solutions to its clientele. Their flagship services, which are pivotal in their revenue generation, include the transformation of intricate scientific research into accessible content, catering to the demands of a diverse healthcare audience. Following the acquisition in June 2016, MedForce aims to leverage new funding to enhance its product offerings and expand into new markets. The company is focused on the development of new services designed to meet the evolving needs of healthcare communication.

Specific plans include targeting expansion into additional European markets by 2025, aiming to enhance their footprint in the healthcare sector. This strategy will be supported by continued investment in technology and talent to strengthen their service delivery and compliance capabilities.